Gene Query: NUDC

Dataset Description Geneva Score
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 47.57
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 41.0
Genome wide miR-191 target profile determined by RIP and gene expression profiling 41.0
4sU-seq of HFF exposed to salt and heat stress 37.82
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 36.83
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 33.67
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 32.3
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 30.91
FOXD3 is a novel tumor suppressor in lung cancer 25.9
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 24.75
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 24.75
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 23.63
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 23.34
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 22.91
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 21.87
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 21.67
MeRIP-seq for heat shock in B-cell lymphoma cells 21.65
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 21.65
miR941 overexpression experiment 20.96
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 20.4
The interplay between SOX4 and SMAD3 in the context of breast cancer 20.37
Identification of transcription start sites for human A549 cell line using ReCappable-seq 20.3
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 20.26
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 19.82
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 19.65
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 18.95
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 18.87
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 18.37
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 18.13
O-glcnAc reprograms cellular energetics 18.02
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 17.82
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 17.72
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 17.55
Targeting EZH2 in MYCN-amplified Neuroblastoma 17.55
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 17.47
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 17.47
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 17.44
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 17.33
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 17.16
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 17.07
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 17.07
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 16.85
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 16.74
Endothelial gene expression analysis 16.69
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 16.69
Transcriptome analysis upon C6orf203 silencing 16.65
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 16.64
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 16.56
CD73 knockdown effect in pancreatic cancer cell lines 16.46
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 16.45
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 16.38
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 16.38
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 16.38
Genome wide expression change by RNF168 knocking down in NEC cells 16.18
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 16.07
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 16.05
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 15.99
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 15.98
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 15.98
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 15.67
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 15.6
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 15.41
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 15.34
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 15.34
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 15.34
Gene expression profiling of leukemia cells following asparagine depletion 15.1
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 15.09
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 14.97
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 14.87
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 14.84
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 14.75
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 14.54
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 14.54
Global analysis of enhancer targets: Mosaic-seq 14.51
Metastasis in triple-negative breast cancer 14.37
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 14.37
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 14.27
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 13.72
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 13.68
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 13.61
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 13.54
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 13.54
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 13.44
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 13.44
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 13.43
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 13.31
EWSR1 influences alternative splicing through direct and indirect mechanisms 13.29
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 13.06
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 12.99
Gene induction by the USP6 oncogene in response to interferon 12.87
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 12.71
Triple vectors expand AAV transfer capacity in the retina 12.64
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 12.59
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 12.49
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 12.46
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 12.46
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 12.32
hnRNP C is a key regulator of protein synthesis in mitosis 12.32
Solid phase chemistry to covalently and reversibly capture thiolated RNA 12.29
RIG-I and MDA5 fRIP during KSHV lytic reactivation 12.26
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 12.25
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 12.09
The landscape of alternative splicing in aggressive prostate cancers 12.03
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 11.8
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 11.74
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 11.63
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 11.59
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 11.54
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 11.49
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 11.46
Expression level comparison under dividing and quiescent states in human primary fibroblasts 11.42
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 11.42
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 11.42
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 11.4
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 11.39
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 11.38
TGF-β regulation of miRNA expression in pancreatic cancer 11.35
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 11.28
Stem and effector CD8 T-cells from human cancers 11.24
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 11.15
Developmental stage specific chromosome architecture in human erythroid cells 11.06
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 11.06
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 11.01
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 11.01
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 11.01
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 10.97
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 10.82
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 10.8
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 10.79
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 10.78
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 10.76
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 10.72
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 10.72
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 10.72
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 10.69
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 10.61
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 10.51
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 10.5
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 10.41
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 10.36
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 10.33
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 10.3
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 10.29
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 10.28
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 10.26
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 10.25
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 10.24
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 10.2
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 10.2
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 10.17
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 10.12
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 10.06
Expression and functions of long noncoding RNAs during human T helper cell differentiation 10.05
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 10.05
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 9.99
A549 cells and MSR-A549 cells 9.99
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 9.98
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 9.98
High-throughput sequencing of PROMPT-enriched samples. 9.95
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 9.91
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 9.89
Gene expression changes after LOC550643 silencing 9.85
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 9.8
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 9.8
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 9.76
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 9.73
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 9.72
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 9.72
Global transcriptome analysis of HAP1 cells 9.7
TOP2B disturbed the quality of human oocytes with advanced maternal age 9.62
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 9.62
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 9.62
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 9.57
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 9.57
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 9.53
Selective expression of long non-coding RNAs in a breast cancer cell progression model 9.53
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 9.48
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 9.43
Gene expression changes caused by KRAS in MCF-10A 9.4
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 9.39
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 9.39
RNA-seq of resting and activated CD4+ T cells +-JQ1 9.34
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 9.31
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 9.29
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 9.29
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 9.23
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 9.15
Transcriptome analysis of human lung epithelial cells 9.14
Transcription control by the ENL YEATS domain in acute leukemia 9.14
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 9.14
Effect of FGF13 depletion on the H460 cell line 9.1
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 9.08
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 9.01
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 9.01
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 9.0
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 9.0
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 8.81
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 8.78
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 8.76
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 8.7
A role for ZNF598 in post-transcriptional gene regulation 8.68
Transcriptome analysis of U87 cells upon LINC00152 knockdown 8.67
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 8.67
Role of microRNAs in the interaction between Salmonella and the host cell 8.67
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 8.64
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 8.63
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 8.61
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 8.61
Hijacking of stress response machinery by oncogenes in acute leukaemia 8.61
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 8.6
RNA-seq analysis of differentiating human erythroblasts 8.58
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 8.57
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 8.52
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 8.52
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 8.51
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 8.5
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 8.49
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 8.46
Total RNA sequencing of WT intestinal orgaonids. 8.44
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 8.41
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 8.4
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 8.39
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 8.38
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 8.36
RNA-seq melanoma 8.33
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 8.26
Transcriptome analysis of kidney organoids 8.23
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 8.19
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 8.17
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 8.17
Genome-wide functional assessment of enhancer activities in the human genome 8.15
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 8.13
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 8.12
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 8.11
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 8.11
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 8.11
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 8.08
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 8.08
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 8.04
Expression data from miR340 overexpressing human A549 cells 8.02
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 7.95
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 7.88
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 7.86
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 7.82
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 7.8
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 7.77
Differential Protein Occupancy Profiling of the mRNA Transcriptome 7.76
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 7.69
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 7.67
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 7.62
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 7.62
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 7.54
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 7.54
RNA expression following TMPRSS11B overexpression or depletion 7.45
A map of gene expression in neutrophil-like cell lines 7.36
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 7.35
Identification of HOXB13 target genes responsive to BET inhibitors 7.31
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 7.29
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 7.29
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 7.29
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 7.28
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 7.25
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 7.18
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 7.18
RNA seq with AML (NB4) cells upon FTO inhibition 7.16
MicroRNA targetome analysis during HCMV infection 7.15
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 7.13
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 7.09
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 7.09
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 7.09
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 7.07
Global expression profiles in cardiac progenitor cells generated by ISX-9 7.07
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 7.04
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 6.98
PTHrP overexpression in MCF7 cells 6.98
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 6.96
U1 snRNP telescripting regulates size-function stratified human genome 6.94
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 6.93
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 6.91
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 6.88
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 6.85
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 6.65
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 6.65
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 6.54
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 6.54
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 6.53
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 6.53
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 6.5
BCL11B 6.42
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 6.39
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 6.35
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 6.35
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 6.32
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 6.31
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 6.13
NR2F2 study 6.13
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 6.08
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 6.01
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 6.0
A single-cell transcriptome atlas of the human pancreas 6.0
HEK293 Heat-shock experiment 5.99
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 5.93
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 5.93
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 5.92
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 5.92
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 5.87
Genome-wide analysis of the Integrator complex (HTS) 5.86
Genome-wide analysis of the Integrator complex 5.86
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 5.83
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 5.73
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 5.72
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 5.62
IMP3 regulated gene expression in breast cancer cells 5.6
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 5.57
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 5.57
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 5.44
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 5.44
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 5.38
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 5.36
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 5.35
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 5.2
FOXP2's impact on the primate transcriptome 5.04
CHCHD2 gene KO effect in iPSC drived motor neurons 5.04
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 5.04
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 5.04
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 4.96
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 4.94
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 4.91
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 4.9
Human Treg NaCl stimulation 4.89
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 4.8
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 4.8
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 4.8
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 4.74
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 4.73
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 4.73
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 4.71
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 4.66
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 4.66
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 4.66
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 4.62
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 4.52
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 4.51
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 4.44
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 4.43
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 4.35
The role of CFTR in islet function 4.34
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 4.32
Gene expression profile in breast cancer cells 4.27
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 4.27
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 4.16
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 4.16
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 4.15
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 3.95
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 3.87
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 3.85
Comparative Analysis of Cas9 Activators Across Multiple Species 3.83
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 3.81
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 3.81
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 3.77
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 3.76
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 3.64
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 3.62
Ribosome profiling upon inhibition of eIF4A 3.61
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 3.55
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 3.55
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 3.55
Global transcriptome analysis of WT versus HEB-/- hESCs 3.53
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 3.52
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 3.46
Positively selected enhancer elements endow tumor cells with metastatic competence 3.44
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 3.42
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 3.39
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 3.37
Global response to chemotherapy-induced apoptosis 3.37
Biological effect of chronic mistranslation in mammalian cells 3.34
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 3.31
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 3.31
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 3.28
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 3.24
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 3.18
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 3.18
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 3.17
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 3.16
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 3.15
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 3.15
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 3.12
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.98
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 2.98
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 2.88
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 2.84
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 2.83
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 2.81
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 2.8
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 2.8
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 2.78
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 2.78
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 2.75
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 2.74
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 2.73
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 2.7
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 2.7
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 2.7
Energy Metabolism during Anchorage-Independence 2.69
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 2.68
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 2.61
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 2.61
Primary Human B-cell Temporal Response to CD40L Stimulation 2.6
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 2.57
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 2.57
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 2.51
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 2.51
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 2.51
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 2.48
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 2.48
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 2.41
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 2.41
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 2.32
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 2.31
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 2.24
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 2.23
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 2.21
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 2.18
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 2.12
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 2.03
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 1.98
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 1.93
Anti-inflammatory effect of indoleacrylic acid (IA) 1.79
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 1.76
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 1.76
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 1.71
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 1.69
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 1.66
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 1.66
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 1.63
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 1.62
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 1.62
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 1.6
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 1.53
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 1.53
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 1.52
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 1.47
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 1.47
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 1.45
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 1.42
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 1.33
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 1.33
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 1.33
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 1.32
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 1.29
Transcriptome profiling of A2M treated A549 Cell Line Samples 1.21
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.2
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 1.17
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 1.11
Gene expression profile of CRC-derived HILEC 1.1
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 1.09
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 1.05
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 1.0
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 0.99
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.98
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 0.97
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 0.91
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 0.87
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 0.87
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.85
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 0.81
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.8
Hepatocyte maturation 0.75
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 0.74
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.74
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.69
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 0.63
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 0.63
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 0.59
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 0.59
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.59
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.58
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.56
Determining mRNA half-lives on a transcriptome-wide scale 0.54
Enhancer activation during EGF response 0.49
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.4
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.4
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.4
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.33
MARS Seq data from human cortical organoids 0.3
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 0.3
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.23
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.23
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.19
RNA-seq data 0.18
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.16
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.15
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 0.12
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.12
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.1
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.05
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.05
MicroRNA-125a-5p overexpression in human macrophages 0.05
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 0.03
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation